Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 211.48%6.8M | -38.52%305.7M | -16.29%122.3M | -33.59%95.5M | -15.01%94M | -106.31%-6.1M | 12.64%497.2M | -40.87%146.1M | 119.54%143.8M | 23.16%110.6M |
Net income from continuing operations | -3.16%30.6M | -273.83%-511.4M | 104.77%14.2M | -15.12%44.9M | -1,210.89%-602.1M | -40.93%31.6M | -144.14%-136.8M | -663.26%-297.4M | -26.01%52.9M | -43.07%54.2M |
Operating gains losses | ---- | -77.11%-35.6M | 59.09%-4.5M | -156.36%-14.1M | -106.06%-6.8M | -3,300.00%-10.2M | -704.00%-20.1M | -1,122.22%-11M | -1,733.33%-5.5M | -450.00%-3.3M |
Depreciation and amortization | -3.95%31.6M | -24.40%136M | -23.88%34.1M | -19.11%36.4M | -27.07%32.6M | -27.53%32.9M | 0.06%179.9M | -1.54%44.8M | 2.04%45M | 0.45%44.7M |
Deferred tax | ---- | 55.11%-58M | 97.59%-2.7M | -0.98%-10.3M | -679.66%-46M | 183.33%1M | -722.93%-129.2M | -3,290.91%-111.9M | 5.56%-10.2M | -63.89%-5.9M |
Other non cash items | 393.10%8.5M | -144.85%-6.1M | 23.40%5.8M | -614.29%-3.6M | -345.45%-5.4M | -148.33%-2.9M | 644.00%13.6M | 161.11%4.7M | 153.85%700K | 246.67%2.2M |
Change In working capital | 21.80%-64.2M | -74.14%30M | -7.22%59.1M | -44.59%33.3M | 79.09%19.7M | -336.70%-82.1M | 248.72%116M | -53.47%63.7M | 234.15%60.1M | 119.75%11M |
-Change in receivables | ---- | -12.55%42.5M | -21.56%56.4M | 560.98%27.1M | -210.91%-12.2M | 25.00%-28.8M | 282.71%48.6M | -12.42%71.9M | 126.11%4.1M | 131.25%11M |
-Change in inventory | ---- | -48.32%44.7M | -79.00%4.2M | -68.05%5.4M | -4.46%34.3M | -94.16%800K | -9.99%86.5M | -74.91%20M | -76.59%16.9M | 1,336.00%35.9M |
-Change in payables and accrued expense | ---- | -163.20%-60.8M | 74.08%-9.9M | -92.93%2.7M | 105.80%1.7M | -991.94%-55.3M | 83.94%-23.1M | -56.56%-38.2M | 135.30%38.2M | -107.80%-29.3M |
-Change in other current assets | ---- | -10.00%3.6M | -16.00%8.4M | -311.11%-1.9M | 37.88%-4.1M | 500.00%1.2M | 208.11%4M | 2,100.00%10M | -86.96%900K | 25.84%-6.6M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 211.48%6.8M | -38.52%305.7M | -16.29%122.3M | -33.59%95.5M | -15.01%94M | -106.31%-6.1M | 12.64%497.2M | -40.87%146.1M | 119.54%143.8M | 23.16%110.6M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 25.96%-7.7M | 59.91%-36.6M | -28.06%-17.8M | 98.65%-200K | 68.70%-8.2M | 71.43%-10.4M | 49.61%-91.3M | 75.09%-13.9M | 83.07%-14.8M | -20.74%-26.2M |
Net PPE purchase and sale | 48.65%-13.3M | 28.30%-81.6M | 6.84%-21.8M | 17.12%-18.4M | 49.18%-15.5M | 31.30%-25.9M | -13.46%-113.8M | 32.76%-23.4M | 10.12%-22.2M | -38.01%-30.5M |
Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net other investing changes | -63.87%5.6M | 100.00%45M | -57.89%4M | 145.95%18.2M | 69.77%7.3M | 1,092.31%15.5M | 837.50%22.5M | 4,850.00%9.5M | 3,800.00%7.4M | 975.00%4.3M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 25.96%-7.7M | 59.91%-36.6M | -28.06%-17.8M | 98.65%-200K | 68.70%-8.2M | 71.43%-10.4M | 49.61%-91.3M | 75.09%-13.9M | 83.07%-14.8M | -20.74%-26.2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 233.15%60.3M | 24.75%-270M | 51.25%-23.4M | -2.86%-129.5M | 9.44%-135.2M | 150.84%18.1M | -25.37%-358.8M | 55.10%-48M | -957.98%-125.9M | -35.36%-149.3M |
Net issuance payments of debt | -18.73%69M | -17.55%-125.9M | -206.85%-15.6M | -103.67%-122.2M | 19.07%-73M | 197.89%84.9M | -2,242.00%-107.1M | 130.48%14.6M | -218.81%-60M | -387.57%-90.2M |
Net common stock issuance | 51.22%-2M | 18.33%-4.9M | 20.00%-400K | 0.00%-200K | -100.00%-200K | 21.15%-4.1M | 90.05%-6M | ---500K | 94.12%-200K | 99.72%-100K |
Cash dividends paid | 89.07%-6.7M | 43.07%-136.3M | 89.23%-6.6M | 89.05%-6.7M | -5.29%-61.7M | -5.15%-61.3M | -4.45%-239.4M | -4.97%-61.3M | -4.26%-61.2M | -4.46%-58.6M |
Net other financing activities | ---- | 53.97%-2.9M | 0.00%-800K | 91.11%-400K | 25.00%-300K | -133.33%-1.4M | -270.59%-6.3M | -33.33%-800K | -1,400.00%-4.5M | 0.00%-400K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 233.15%60.3M | 24.75%-270M | 51.25%-23.4M | -2.86%-129.5M | 9.44%-135.2M | 150.84%18.1M | -25.37%-358.8M | 55.10%-48M | -957.98%-125.9M | -35.36%-149.3M |
Net cash flow | ||||||||||
Beginning cash position | ---- | 15.48%365.5M | 1.20%277.2M | 12.70%307M | 4.88%361.3M | 15.48%365.5M | -12.50%316.5M | 21.09%273.9M | 0.93%272.4M | 5.26%344.5M |
Current changes in cash | ---- | -101.91%-900K | -3.68%81.1M | -1,203.23%-34.2M | 23.88%-49.4M | -93.52%1.6M | 281.15%47.1M | -0.24%84.2M | 109.17%3.1M | -53.79%-64.9M |
Effect of exchange rate changes | ---- | -857.89%-14.4M | -209.46%-8.1M | 375.00%4.4M | 31.94%-4.9M | -275.76%-5.8M | 109.90%1.9M | 25.42%7.4M | 83.84%-1.6M | 52.63%-7.2M |
End cash Position | ---- | -4.19%350.2M | -4.19%350.2M | 1.20%277.2M | 12.70%307M | 4.88%361.3M | 15.48%365.5M | 15.48%365.5M | 21.09%273.9M | 0.93%272.4M |
Free cash flow | 79.69%-6.5M | -41.55%224.1M | -18.09%100.5M | -36.60%77.1M | -2.00%78.5M | -154.24%-32M | 12.40%383.4M | -42.20%122.7M | 198.04%121.6M | 18.32%80.1M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |